Analysis of Group 2 Innate Lymphoid Cells in Peripheral Blood


About this study

The primary objective of this study is to investigate the contribution of group 2 innate lymphoid cells (ILC2s) to the immunologic mechanisms of chronic airway diseases.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  1. Ages 18-65;
  2. Meet clinical definition of CRS, which is 12 weeks with at least 2 of the major criteria for diagnosis (nasal discharge, nasal obstruction, facial congestion, facial pain-pressure-fullness, or a decrease in smell) within the past 24 months
  3. Have a sinus CT scan within the past 24 months with a Lund-Mackay score >5
  4. Nasal polyps must be documented within the past 3 years on physical exam and endoscopy

Normal controls are healthy individuals with no history of allergy or CRS, normal spirometry, and negative skin prick test results or negative IgE serum tests to 6 common aeroallergens, including house dust mite, Alternaria, cat/dog dander, ragweed, orchard grass, and oak. 


Exclusion Criteria:

  1. Cystic fibrosis
  2. Primary ciliary dyskinesia
  3. Immune deficiency disorders
  4. Current cigarette smoking >1 cigarette/day
  5. Oral corticosteroids or high-dose inhaled corticosteroids in the past 6 weeks before enrollment
  6. On any biologics treatment
  7. A lower or upper airway infection (e.g., ‘cold’) in the last 4 weeks.
  8. Pregnant women
  9. Prisoners
  10. CRS patients without nasal polyps or with other underlying medical illnesses that accompany chronic sinusitis (primary ciliary dyskinesia, cystic fibrosis, and immune deficiency)


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Hirohito Kita, M.D.

Open for enrollment

Contact information:

Kay Bachman R.N., C.C.R.C.


More information


Publications are currently not available

Mayo Clinic Footer